Clinical Trials Logo

Clinical Trial Summary

There is a need to develop a better understanding of the early phase of bipolar disorder, and to develop and evaluate effective psychosocial interventions that assist people in this phase. The purpose of this study is to determine whether or not it is feasible to conduct a larger study of the effectiveness of cognitive interpersonal therapy (a psychological therapy) with individuals who have experienced their first or second treated episode of mania or hypomania (symptoms common in early development of bipolar disorders).


Clinical Trial Description

The 'PICO' framework (Oxman, Sackett, and Guyatt, 1993; Richardson, Wilson, Nishikawa, and Hayward; 1995) was used to specify the parameters of the study aims and objectives:

1. Population: could appropriate individuals be identified and recruited to a trial of CIT for early bipolar disorder?

2. Intervention: would CIT be an acceptable intervention for individuals following a first or second treated episode of mania and or hypomania? Could we identify any modifications required to the CIT protocol used with this group?

3. Control group: could an appropriate group of participants be recruited to facilitate a comparison with the CIT intervention? Could we explicitly establish the usual care package and its local implementation?

4. Outcomes: which outcomes are appropriate for measuring relevant dimensions of a treatment effect? ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01315028
Study type Interventional
Source NHS Greater Glasgow and Clyde
Contact
Status Completed
Phase N/A
Start date November 2010
Completion date October 2011

See also
  Status Clinical Trial Phase
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Completed NCT00534222 - Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect N/A
Completed NCT00140179 - Valnoctamide in Mania Phase 3
Completed NCT01237379 - Peroxisomal Defects and Familial Risk for Bipolar Disorder N/A
Completed NCT00254488 - Treatment of Bipolar Mania in Older Adults Phase 4
Completed NCT00560079 - Efficacy of Allopurinol and Dypiridamole in Acute Mania Phase 4
Completed NCT00518947 - Pharmacotherapy of Treatment-Resistant Mania Phase 3
Recruiting NCT05444907 - Deep Brain Stimulation-Induced Mania in Parkinson's Disease
Enrolling by invitation NCT02360267 - Pediatric Bipolar Registry
Completed NCT01092221 - Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode Phase 3
Completed NCT00521365 - Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder. Phase 4
Completed NCT01191918 - The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania Phase 4
Completed NCT01541605 - Methylphenidate for the Treatment of Acute Mania Phase 3
Completed NCT00893581 - Multimodal Neuroimaging of Treatment Effects in Adolescent Mania N/A
Completed NCT00208195 - Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase 4
Completed NCT00181922 - Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder Phase 4
Completed NCT00181935 - Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder Phase 4
Active, not recruiting NCT05703711 - Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa N/A
Completed NCT00917501 - Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania Phase 2
Completed NCT00334347 - A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR Phase 4